Total Payments
$3,560
2024 Payments
$472.64
Companies
35
Transactions
201
Medicare Patients
4,643
Medicare Billing
$331,195
Payment Breakdown by Category
Food & Beverage$3,446 (96.8%)
Education$113.88 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,446 | 199 | 96.8% |
| Education | $113.88 | 2 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $559.65 | 36 | $0 (2024) |
| PFIZER INC. | $335.24 | 21 | $0 (2023) |
| Novo Nordisk Inc | $248.41 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $234.16 | 17 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $216.28 | 13 | $0 (2024) |
| Amgen Inc. | $197.66 | 4 | $0 (2024) |
| ABBVIE INC. | $178.92 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $159.76 | 11 | $0 (2021) |
| GlaxoSmithKline, LLC. | $158.95 | 10 | $0 (2023) |
| Lilly USA, LLC | $153.49 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $472.64 | 17 | Amgen Inc. ($150.00) |
| 2023 | $364.95 | 19 | GlaxoSmithKline, LLC. ($55.90) |
| 2022 | $382.45 | 21 | Biohaven Pharmaceutical Holding Company Ltd. ($71.94) |
| 2021 | $609.48 | 38 | Biohaven Pharmaceuticals, Inc. ($98.21) |
| 2020 | $375.14 | 25 | AstraZeneca Pharmaceuticals LP ($98.57) |
| 2019 | $412.64 | 27 | AstraZeneca Pharmaceuticals LP ($179.48) |
| 2018 | $463.48 | 26 | PFIZER INC. ($139.60) |
| 2017 | $479.11 | 28 | Astellas Pharma US Inc ($118.01) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 4 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: PRIMARY CARE | ||||||
| 04/29/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Gastroenterology | ||||||
| 04/28/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: PRIMARY CARE | ||||||
| 04/26/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Inflammation | ||||||
| 04/21/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: RESPIRATORY | ||||||
| 04/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.76 | General |
| Category: Neurology | ||||||
| 03/30/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: DIABETES | ||||||
| 03/18/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: PRIMARY CARE | ||||||
| 03/11/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 03/03/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Obesity | ||||||
| 03/03/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Gastroenterology | ||||||
| 02/23/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Diabetes | ||||||
| 02/23/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: RESPIRATORY | ||||||
| 02/16/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/01/2021 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Diabetes | ||||||
| 01/19/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2020 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $21.05 | General |
| 12/03/2020 | Medtronic USA, Inc. | KYPHON Balloon Kyphoplasty (Device) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 11/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,010 | 1,712 | $149,752 | $71,756 |
| 2022 | 17 | 1,031 | 1,773 | $156,918 | $73,453 |
| 2021 | 16 | 1,099 | 2,047 | $179,352 | $86,025 |
| 2020 | 17 | 1,503 | 2,676 | $248,375 | $99,961 |
Total Patients
4,643
Total Services
8,208
Medicare Billing
$331,195
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 490 | $72,030 | $37,691 | 52.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 106 | 106 | $26,500 | $12,822 | 48.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 84 | 84 | $13,860 | $6,442 | 46.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 64 | 191 | $9,741 | $4,482 | 46.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 30 | 30 | $2,400 | $2,274 | 94.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 96 | 96 | $3,360 | $1,621 | 48.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 93 | 93 | $3,255 | $1,569 | 48.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 40 | $1,800 | $1,126 | 62.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 61 | 123 | $4,920 | $1,115 | 22.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 122 | $4,392 | $1,108 | 25.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 115 | 156 | $2,184 | $506.10 | 23.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 27 | 30 | $1,500 | $360.15 | 24.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 24 | 34 | $1,360 | $260.85 | 19.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 28 | $280.00 | $218.64 | 78.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $650.00 | $131.04 | 20.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 18 | 76 | $1,520 | $29.17 | 1.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 192 | 550 | $80,850 | $40,317 | 49.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 127 | 127 | $31,750 | $15,776 | 49.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 60 | 61 | $10,065 | $4,914 | 48.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 34 | 34 | $2,720 | $2,389 | 87.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 46 | 77 | $3,927 | $1,947 | 49.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 69 | 153 | $6,120 | $1,431 | 23.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 50 | 154 | $5,544 | $1,402 | 25.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 43 | $1,935 | $1,169 | 60.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 52 | 52 | $1,820 | $892.14 | 49.0% |
About Dr. Roy Deen, M.D
Dr. Roy Deen, M.D is a Family Medicine healthcare provider based in Milledgeville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437263340.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roy Deen, M.D has received a total of $3,560 in payments from pharmaceutical and medical device companies, with $472.64 received in 2024. These payments were reported across 201 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,446).
As a Medicare-enrolled provider, Deen has provided services to 4,643 Medicare beneficiaries, totaling 8,208 services with total Medicare billing of $331,195. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Milledgeville, GA
- Active Since 08/18/2006
- Last Updated 05/18/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437263340
Products in Payments
- FARXIGA (Drug) $328.97
- XIFAXAN (Drug) $216.28
- XARELTO (Drug) $179.19
- NURTEC ODT (Drug) $170.15
- KRYSTEXXA (Biological) $150.00
- SYMBICORT (Drug) $138.44
- CHANTIX (Drug) $136.69
- TRELEGY ELLIPTA (Drug) $133.15
- VRAYLAR (Drug) $118.71
- ELIQUIS (Drug) $118.19
- TRINTELLIX (Drug) $104.77
- Ozempic (Drug) $93.85
- TRADJENTA (Drug) $83.74
- QUVIVIQ (Drug) $83.67
- MOUNJARO (Drug) $67.89
- Tresiba (Drug) $65.82
- Rybelsus (Drug) $57.26
- INVOKANA (Drug) $54.97
- TRULICITY (Drug) $53.74
- Cologuard Collection Kit (Device) $52.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Milledgeville
Dr. Michael Duke, M.d, M.D
Family Medicine — Payments: $7,953
Family Medicine $7,953
Dr. James Smith, M.d, M.D
Family Medicine — Payments: $7,636
Family Medicine $7,636
Elizabeth Furbish, Md, MD
Family Medicine — Payments: $671.54
Family Medicine $671.54
James Kelly, M.d, M.D
Family Medicine — Payments: $119.64
Family Medicine $119.64
Dr. Charles Caulton, Md, MD
Family Medicine
Family Medicine
Dr. Ronald Boyd, Md, MD
Family Medicine
Family Medicine